{'fraction_non_alphanumeric': 0.020080321285140562, 'fraction_numerical': 0.0, 'mean_word_length': 5.653333333333333, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Use of inferior vena caval filters and survival in patients with malignancy

Inferior vena cava (IVC) filters have proven to be a viable alternative to anticoagulation therapy for the prevention of life‐threatening pulmonary emboli (PE) for patients who have contraindications to anticoagulation therapy. The clinical benefit of placing IVC filters in patients with advanced‐stage cancer is controversial. The current study reported the authors' experience with IVC filters in patients with cancer.